Anika Therapeutics, Inc. (ANIK)
10.83
-0.09
(-0.82%)
USD |
NASDAQ |
Feb 24, 16:00
10.83
0.00 (0.00%)
After-Hours: 20:00
Anika Therapeutics Shareholders Equity (Quarterly) : 146.80M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 5.054M |
| BioStem Technologies, Inc. | 50.02M |
| Iovance Biotherapeutics, Inc. | 702.29M |
| Protokinetix, Inc. | 0.2504M |
| GB Sciences, Inc. | -5.88M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 189.44M |
| Total Liabilities (Quarterly) | 42.63M |
| Debt to Equity Ratio | 0.1669 |
| Current Ratio | 5.322 |
| Net Debt Paydown Yield | 0.53% |